Singapore-based RVAC Medicines collaborates with University of Pennsylvania for mRNA vaccine research

RVAC Medicines, Inc., a messenger RNA (mRNA) technology company with its global headquarters in Singapore, has anno...

March 20, 2023 | Monday | News
Takeda’s dengue vaccine receives first approval in Latin America

Japanese pharmaceutical company Takeda's dengue vaccine, QDENGA  (Dengue Tetravalent Vaccine [Live, Attenuated...

March 15, 2023 | Wednesday | News
Korea's LG Chem to supply UNICEF with $200 M worth of essential vaccines

South Korean firm LG Chem has announced that it will supply essential vaccines, including polio vaccines, for infants an...

March 15, 2023 | Wednesday | News
New funding bolsters medical and science research collaborations in Australia

Australia's University of Sydney medical and science researchers will be involved in two successful Cooperative Res...

February 27, 2023 | Monday | News
Clover Biopharma to commercialise quadrivalent seasonal influenza vaccine in China

Clover Biopharmaceuticals has entered into an exclusive agreement with Adimmune Corporation for Clover to dist...

February 22, 2023 | Wednesday | News
Korea's GC Biopharma receives WHO prequalification for chickenpox vaccine

GC Biopharma, a leading provider of biopharmaceutical products in South Korea, has announced that the World Health Organ...

February 22, 2023 | Wednesday | News
Funding injection of $8 M for Strep A vaccine research in Australia

Australia's University of Queensland (UQ)-led research effort to develop an mRNA vaccine against Group A Streptococcus (...

February 20, 2023 | Monday | News
Clover Biopharma launches COVID-19 booster vaccine in China

Clover Biopharmaceuticals has announced that the launch of its COVID-19 vaccine, a recombinant SARS-CoV-2 subunit v...

February 16, 2023 | Thursday | News
SK bioscience invests $261 M to establish vaccine-biopharma hub in Korea

SK bioscience, a South Korea-based innovative vaccine and biotech company committed to promoting human health from preve...

February 9, 2023 | Thursday | News
Japanese firm Mitsubishi Tanabe stops commercialisation of COVID-19 vaccine

Japan-based Mitsubishi Chemical Group has decided to cease all of its operations at Medicago Inc., a Canadian subs...

February 6, 2023 | Monday | News
Australia further expands access to Japanese encephalitis vaccine

New South Wales (NSW) in Australia is further expanding free access to Japanese encephalitis (JE) vaccine to ensure resi...

January 31, 2023 | Tuesday | News
Korea's International Vaccine Institute opens Country Office in Austria

The International Vaccine Institute (IVI), based in Seoul (South Korea) has launched an IVI Country Office in&...

January 25, 2023 | Wednesday | News
Korea gives fast track approval to promising DNA vaccine for advanced cervical cancer

Genexine, a clinical-staged Korean biopharmaceutical company committed to the discovery and development of novel biologi...

January 23, 2023 | Monday | News
South Korea approves Novavax Nuvaxovid COVID-19 vaccine as adult booster

US-based Novavax, Inc. has announced that partner SK bioscience, based in South Korea, has received expanded manufacturi...

January 19, 2023 | Thursday | News
Hayat-Vax to be first COVID-19 vaccine produced in Arab world

In a historic move in the global fight against the COVID-19 pandemic, the United Arab Emirates (UAE) has announced the c...

January 17, 2023 | Tuesday | News
New partnerships in Korea to transform mRNA technology into more vaccines

Gachon University, the Korea mRNA Vaccine Initiative (KmVAC), and the International Vaccine Institute (IVI) recently exc...

January 16, 2023 | Monday | News
World's second developed shingles vaccine receives biologics license application approval in Malaysia

South Korea headquatered SK bioscience, a global innovative vaccine and biotech company, has received a biologics licens...

January 12, 2023 | Thursday | News
Demand booms for experimental mRNA in Australia

The University of Queensland (UQ) team has become the biggest supplier of experimental mRNA vaccines and therapies ...

January 12, 2023 | Thursday | News